Evaluation of the protective effects of β-blockers in the management of acute exacerbations of chronic obstructive pulmonary disease.
Cameron D ThomasLori H DupreeMarci DeLosSantosJason A FerreiraPublished in: Journal of clinical pharmacy and therapeutics (2018)
β-blocker therapy could result in a paradigm shift in managing chronic obstructive pulmonary disease patients from a true cardiopulmonary approach. This retrospective cohort study demonstrated early β-blocker continuation in patients admitted for an AECOPD was associated with less major inpatient events, primarily arrhythmias.
Keyphrases
- chronic obstructive pulmonary disease
- end stage renal disease
- angiotensin converting enzyme
- newly diagnosed
- ejection fraction
- chronic kidney disease
- liver failure
- prognostic factors
- mental health
- palliative care
- lung function
- respiratory failure
- angiotensin ii
- drug induced
- acute care
- intensive care unit
- hepatitis b virus
- air pollution